Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
ASSETS
Cash and cash equivalents	$ 283,341	$ 259,701
Grant funds and other receivables	68,603	121,814
Prepaid expenses and other current assets	95,320	238,189
Total current assets	447,264	619,704
Property and equipment, net (Note 3)	10,606	11,350
Deposits	11,010	11,010
Total assets	468,880	642,064
Current liabilities:
Accounts payable	152,653	125,859
Accrued expenses (Note 4)	1,851,040	1,238,552
Current portion of notes payable (Note 5)	12,500	260,420
Total current liabilities	2,016,193	1,624,831
Note payable, net of current portion (Note 5)	27,243	39,580
Total liabilities	2,043,436	1,664,411
Commitments (Note 6)
Stockholders’ equity (deficiency):
Preferred stock, $.01 par value (Note 7): Authorized shares – 10,000,000 Issued and outstanding shares – 2,486 and 3,450 at December 31, 2019 and 2018, respectively	1,932,433	1,971,333
Common stock, $.001 par value: Authorized shares – 600,000,000 Issued and outstanding shares – 299,835 and 219 at December 31, 2019 and 2018, respectively	300
Additional paid-in capital	39,340,224	37,483,204
Accumulated deficit	(42,847,513)	(40,476,884)
Total stockholders’ equity (deficiency)	(1,574,556)	(1,022,347)
Total liabilities and stockholders’ equity (deficiency)	$ 468,880	$ 642,064